Jirón M I, Delhotal B, Lebrec D
Eur J Clin Pharmacol. 1985;28(3):353-5. doi: 10.1007/BF00543337.
Fifty-two patients with cirrhosis receiving continuous administration of propranolol in doses reducing the heart rate by 25% were studied. The doses and plasma levels varied widely - 185 +/- 98 mg/day (mean +/- SD) and 208 +/- 153 ng/ml, respectively. These values were significantly correlated. No significant correlation was found between the dose of the drug or plasma level and the liver function tests. Although propranolol significantly decreased cardiac output and the hepatic venous pressure gradient, no correlation was found between drug dose or plasma level and these haemodynamic effects.
对52例接受普萘洛尔持续给药且剂量能使心率降低25%的肝硬化患者进行了研究。剂量和血浆水平差异很大,分别为185±98mg/天(均值±标准差)和208±153ng/ml。这些值显著相关。未发现药物剂量或血浆水平与肝功能检查之间存在显著相关性。虽然普萘洛尔显著降低了心输出量和肝静脉压力梯度,但未发现药物剂量或血浆水平与这些血流动力学效应之间存在相关性。